ATE544846T1 - Fusionierte mesenchymale stammzellen zur behandlung von diabetes und verfahren dafür - Google Patents

Fusionierte mesenchymale stammzellen zur behandlung von diabetes und verfahren dafür

Info

Publication number
ATE544846T1
ATE544846T1 AT07861344T AT07861344T ATE544846T1 AT E544846 T1 ATE544846 T1 AT E544846T1 AT 07861344 T AT07861344 T AT 07861344T AT 07861344 T AT07861344 T AT 07861344T AT E544846 T1 ATE544846 T1 AT E544846T1
Authority
AT
Austria
Prior art keywords
methods
fusioned
stem cells
mesenchymal stem
treating diabetes
Prior art date
Application number
AT07861344T
Other languages
English (en)
Inventor
Christof Westenfelder
Original Assignee
Insugen Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insugen Llc filed Critical Insugen Llc
Application granted granted Critical
Publication of ATE544846T1 publication Critical patent/ATE544846T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07861344T 2006-09-19 2007-09-19 Fusionierte mesenchymale stammzellen zur behandlung von diabetes und verfahren dafür ATE544846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84571206P 2006-09-19 2006-09-19
PCT/US2007/020359 WO2008036349A2 (en) 2006-09-19 2007-09-19 Fused stem cells useful for the treatment of diabetes and methods thereof

Publications (1)

Publication Number Publication Date
ATE544846T1 true ATE544846T1 (de) 2012-02-15

Family

ID=39201090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07861344T ATE544846T1 (de) 2006-09-19 2007-09-19 Fusionierte mesenchymale stammzellen zur behandlung von diabetes und verfahren dafür

Country Status (6)

Country Link
US (2) US8119120B2 (de)
EP (1) EP2061874B1 (de)
AT (1) ATE544846T1 (de)
CA (1) CA2693382C (de)
DK (1) DK2061874T3 (de)
WO (1) WO2008036349A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008036349A2 (en) 2006-09-19 2008-03-27 Insugen, Llc Fused stem cells useful for the treatment of diabetes and methods thereof
WO2015058139A1 (en) * 2013-10-18 2015-04-23 Symbiocelltech, Llc Stem cell / islet cell hybrids, generation thereof, and methods for the treatment and cure of insulin-dependent diabetes mellitus
CA2995599C (en) * 2015-09-10 2021-07-27 Symbiocelltech, Llc Neo-islets comprising stem and islet cells and treatment of diabetes mellitus therewith

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US6881555B2 (en) * 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
WO2004090112A2 (en) 2003-04-01 2004-10-21 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
US20060084167A1 (en) * 2004-10-16 2006-04-20 Cohenford Menashi A Formation of Hybrid Cells by Fusion of Lineage Committed Cells with Stem Cells
WO2008036349A2 (en) 2006-09-19 2008-03-27 Insugen, Llc Fused stem cells useful for the treatment of diabetes and methods thereof

Also Published As

Publication number Publication date
DK2061874T3 (da) 2012-05-29
EP2061874A2 (de) 2009-05-27
CA2693382A1 (en) 2008-03-27
EP2061874B1 (de) 2012-02-08
CA2693382C (en) 2013-09-17
US8372641B2 (en) 2013-02-12
US8119120B2 (en) 2012-02-21
WO2008036349A3 (en) 2008-06-26
US20120148551A1 (en) 2012-06-14
EP2061874A4 (de) 2010-01-06
WO2008036349A2 (en) 2008-03-27
US20100034866A1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
EP3124601B1 (de) Gereinigte zusammensetzungen aus mesenchymalen stammzellen sowie verfahren zur reinigung von zusammensetzungen aus mesenchymalen stammzellen
WO2011082038A3 (en) Improved reprogramming compositions
WO2010124142A3 (en) Cell compositions derived from dedifferentiated reprogrammed cells
MY163057A (en) Means and methods for trating dlblcl
BRPI0819609A2 (pt) Diferenciação de células-tronco embrionárias de ser humano
EP2352523A4 (de) Verbesserte anti-cd19-antikörper
MX382822B (es) Metodos y productos para transfeccion de celulas.
MX359551B (es) Agentes de union diana contra b7-h1.
DE60324430D1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
WO2011097181A3 (en) Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
TW200740416A (en) Corneal onlays and related methods
TN2009000190A1 (en) Lingo binding molecules and pharmaceutical use thereof
MX2009013194A (es) Proteinas de fusion del receptor para productos finales de glicacion avanzada.
TW200637574A (en) Treatment method
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
DE602007003331D1 (de) Verfahren zur bestimmung der kopienummer
EP2379577A4 (de) Zusammensetzungen und verfahren zur umprogrammierung von zellen ohne genetische modifikation
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
EA201300133A1 (ru) Фармацевтическая композиция и способ лечения ожирения, сопутствующих метаболических расстройств и зависимости от психоактивных веществ
BR112014031874A2 (pt) método para preparar células-tronco em concentração elevada
WO2011163531A3 (en) Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
DE602007002625D1 (de) Verwendung von botulintoxin zur linderung von hodenschmerzen
PH12013500141A1 (en) Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
DE602006016468D1 (de) Verfahren zur abgabe von fusionspolypeptid in eine zelle
NZ606969A (en) A method of treating alzheimer’s disease